Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Adam

Showing results (531-540 of 555) with videos related to

Pageof 56
Sort By:
Journal of Medicinal Chemistry|June 2, 2012
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitorsLalgudi S Harikrishnan, Heather J Finlay, Jennifer X Qiao, et al.
Journal of Medical Genetics|March 7, 2009
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotypeT Kleefstra, W A van Zelst-Stams, W M Nillesen, et al.
Cell Systems|October 23, 2020
Large-Scale Multi-omic Analysis of COVID-19 SeverityKatherine A Overmyer, Evgenia Shishkova, Ian J Miller, et al.
American Journal of Medical Genetics. Part A|June 6, 2020
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapyTara L Wenger, Randall A Bly, Natalie Wu, et al.
JAMA|February 8, 2018
Prevalence of Fetal Alcohol Spectrum Disorders in 4 US CommunitiesPhilip A May, Christina D Chambers, Wendy O Kalberg, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Large-scale Multi-omic Analysis of COVID-19 SeverityKatherine A Overmyer, Evgenia Shishkova, Ian J Miller, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor modelsCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.
Cancer Immunology Research|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor EfficacyCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.
Prenatal Diagnosis|November 14, 2024
Fetal Presentation of MYRF-Related Cardiac Urogenital Syndrome: An Emerging and Challenging Prenatal DiagnosisMaud Favier, Elise Brischoux-Boucher, Louise C Pyle, et al.
Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.
Pageof 56

Showing results (531-540 of 555) with videos related to

Sort By:
Pageof 56
Journal of Medicinal Chemistry|June 2, 2012
Diphenylpyridylethanamine (DPPE) derivatives as cholesteryl ester transfer protein (CETP) inhibitorsLalgudi S Harikrishnan, Heather J Finlay, Jennifer X Qiao, et al.
Journal of Medical Genetics|March 7, 2009
Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotypeT Kleefstra, W A van Zelst-Stams, W M Nillesen, et al.
Cell Systems|October 23, 2020
Large-Scale Multi-omic Analysis of COVID-19 SeverityKatherine A Overmyer, Evgenia Shishkova, Ian J Miller, et al.
American Journal of Medical Genetics. Part A|June 6, 2020
Activating variants in PDGFRB result in a spectrum of disorders responsive to imatinib monotherapyTara L Wenger, Randall A Bly, Natalie Wu, et al.
JAMA|February 8, 2018
Prevalence of Fetal Alcohol Spectrum Disorders in 4 US CommunitiesPhilip A May, Christina D Chambers, Wendy O Kalberg, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Large-scale Multi-omic Analysis of COVID-19 SeverityKatherine A Overmyer, Evgenia Shishkova, Ian J Miller, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor modelsCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.
Cancer Immunology Research|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor EfficacyCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.
Prenatal Diagnosis|November 14, 2024
Fetal Presentation of MYRF-Related Cardiac Urogenital Syndrome: An Emerging and Challenging Prenatal DiagnosisMaud Favier, Elise Brischoux-Boucher, Louise C Pyle, et al.
Genetics in Medicine Open|November 1, 2024
Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testingJonathan Marquez, Jennifer N Cech, Cate R Paschal, et al.
Pageof 56